APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuroleptic

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neuroleptic Market Analysis and Forecast 2026-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchNeuroleptic Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroleptic Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Neuroleptic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroleptic Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroleptic Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Neuroleptic market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neuroleptic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neuroleptic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neuroleptic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neuroleptic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neuroleptic include Johnson & Johnso, Eli Lilly, Pfizer, GlaxoSmithKline and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neuroleptic, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neuroleptic, also provides the sales of main regions and countries. Of the upcoming market potential for Neuroleptic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuroleptic sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neuroleptic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neuroleptic sales, projected growth trends, production technology, application and end-user industry.

Neuroleptic Segment by Company

Johnson & Johnso

Eli Lilly

Pfizer

GlaxoSmithKline

Bristol-Myers Squibb

Neuroleptic Segment by Type

Droperidol

Midazolam

Neuroleptic Segment by Application

Medical Care

Scientific Research

Others

Neuroleptic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroleptic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroleptic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroleptic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neuroleptic in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neuroleptic manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuroleptic sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neuroleptic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Droperidol Major Manufacturers Table 3. Midazolam Major Manufacturers Table 4. Global Neuroleptic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Care Major Manufacturers Table 6. Scientific Research Major Manufacturers Table 7. Others Major Manufacturers Table 8. Neuroleptic Industry Trends Table 9. Neuroleptic Industry Drivers Table 10. Neuroleptic Industry Opportunities and Challenges Table 11. Neuroleptic Industry Restraints Table 12. Global Neuroleptic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Neuroleptic Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Neuroleptic Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Neuroleptic Revenue Market Share by Region (2021-2026) Table 16. Global Neuroleptic Revenue Market Share by Region (2027-2032) Table 17. Global Neuroleptic Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Neuroleptic Sales by Region (2021-2026) & (K Units) Table 19. Global Neuroleptic Sales by Region (2027-2032) & (K Units) Table 20. Global Neuroleptic Sales Market Share by Region (2021-2026) Table 21. Global Neuroleptic Sales Market Share by Region (2027-2032) Table 22. Global Neuroleptic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Neuroleptic Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Neuroleptic Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Neuroleptic Sales Market Share by Manufacturers (2021-2026) Table 26. Global Neuroleptic Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Neuroleptic Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Neuroleptic Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Neuroleptic Manufacturers, Product Type & Application Table 30. Global Neuroleptic Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Neuroleptic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Neuroleptic Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Neuroleptic Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Neuroleptic Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Neuroleptic Revenue Market Share by Type (2021-2026) Table 37. Global Neuroleptic Revenue Market Share by Type (2027-2032) Table 38. Global Neuroleptic Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Neuroleptic Sales by Type (2021-2026) & (K Units) Table 40. Global Neuroleptic Sales by Type (2027-2032) & (K Units) Table 41. Global Neuroleptic Sales Market Share by Type (2021-2026) Table 42. Global Neuroleptic Sales Market Share by Type (2027-2032) Table 43. Global Neuroleptic Price by Type (2021-2026) & (US$/Unit) Table 44. Global Neuroleptic Price by Type (2027-2032) & (US$/Unit) Table 45. Global Neuroleptic Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Neuroleptic Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Neuroleptic Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Neuroleptic Revenue Market Share by Application (2021-2026) Table 49. Global Neuroleptic Revenue Market Share by Application (2027-2032) Table 50. Global Neuroleptic Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Neuroleptic Sales by Application (2021-2026) & (K Units) Table 52. Global Neuroleptic Sales by Application (2027-2032) & (K Units) Table 53. Global Neuroleptic Sales Market Share by Application (2021-2026) Table 54. Global Neuroleptic Sales Market Share by Application (2027-2032) Table 55. Global Neuroleptic Price by Application (2021-2026) & (US$/Unit) Table 56. Global Neuroleptic Price by Application (2027-2032) & (US$/Unit) Table 57. Johnson & Johnso Company Information Table 58. Johnson & Johnso Business Overview Table 59. Johnson & Johnso Neuroleptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Johnson & Johnso Neuroleptic Product Portfolio Table 61. Johnson & Johnso Recent Development Table 62. Eli Lilly Company Information Table 63. Eli Lilly Business Overview Table 64. Eli Lilly Neuroleptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Eli Lilly Neuroleptic Product Portfolio Table 66. Eli Lilly Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Neuroleptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Pfizer Neuroleptic Product Portfolio Table 71. Pfizer Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Neuroleptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Neuroleptic Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Bristol-Myers Squibb Company Information Table 78. Bristol-Myers Squibb Business Overview Table 79. Bristol-Myers Squibb Neuroleptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bristol-Myers Squibb Neuroleptic Product Portfolio Table 81. Bristol-Myers Squibb Recent Development Table 82. North America Neuroleptic Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Neuroleptic Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Neuroleptic Sales by Type (2021-2026) & (K Units) Table 85. North America Neuroleptic Sales by Type (2027-2032) & (K Units) Table 86. North America Neuroleptic Sales Price by Type (2021-2026) & (US$/Unit) Table 87. North America Neuroleptic Sales Price by Type (2027-2032) & (US$/Unit) Table 88. North America Neuroleptic Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Neuroleptic Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Neuroleptic Sales by Application (2021-2026) & (K Units) Table 91. North America Neuroleptic Sales by Application (2027-2032) & (K Units) Table 92. North America Neuroleptic Sales Price by Application (2021-2026) & (US$/Unit) Table 93. North America Neuroleptic Sales Price by Application (2027-2032) & (US$/Unit) Table 94. North America Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Neuroleptic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Neuroleptic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Neuroleptic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 98. North America Neuroleptic Sales by Country (2021-2026) & (K Units) Table 99. North America Neuroleptic Sales by Country (2027-2032) & (K Units) Table 100. North America Neuroleptic Sales Price by Country (2021-2026) & (US$/Unit) Table 101. North America Neuroleptic Sales Price by Country (2027-2032) & (US$/Unit) Table 102. United States Neuroleptic Revenue (2021-2032) & (US$ Million) Table 103. Canada Neuroleptic Revenue (2021-2032) & (US$ Million) Table 104. Mexico Neuroleptic Revenue (2021-2032) & (US$ Million) Table 105. Europe Neuroleptic Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Neuroleptic Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Neuroleptic Sales by Type (2021-2026) & (K Units) Table 108. Europe Neuroleptic Sales by Type (2027-2032) & (K Units) Table 109. Europe Neuroleptic Sales Price by Type (2021-2026) & (US$/Unit) Table 110. Europe Neuroleptic Sales Price by Type (2027-2032) & (US$/Unit) Table 111. Europe Neuroleptic Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Neuroleptic Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Neuroleptic Sales by Application (2021-2026) & (K Units) Table 114. Europe Neuroleptic Sales by Application (2027-2032) & (K Units) Table 115. Europe Neuroleptic Sales Price by Application (2021-2026) & (US$/Unit) Table 116. Europe Neuroleptic Sales Price by Application (2027-2032) & (US$/Unit) Table 117. Europe Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Neuroleptic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Neuroleptic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Neuroleptic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 121. Europe Neuroleptic Sales by Country (2021-2026) & (K Units) Table 122. Europe Neuroleptic Sales by Country (2027-2032) & (K Units) Table 123. Europe Neuroleptic Sales Price by Country (2021-2026) & (US$/Unit) Table 124. Europe Neuroleptic Sales Price by Country (2027-2032) & (US$/Unit) Table 125. Germany Neuroleptic Revenue (2021-2032) & (US$ Million) Table 126. France Neuroleptic Revenue (2021-2032) & (US$ Million) Table 127. U.K. Neuroleptic Revenue (2021-2032) & (US$ Million) Table 128. Italy Neuroleptic Revenue (2021-2032) & (US$ Million) Table 129. Russia Neuroleptic Revenue (2021-2032) & (US$ Million) Table 130. Spain Neuroleptic Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Neuroleptic Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Neuroleptic Revenue (2021-2032) & (US$ Million) Table 133. Sweden Neuroleptic Revenue (2021-2032) & (US$ Million) Table 134. Poland Neuroleptic Revenue (2021-2032) & (US$ Million) Table 135. China Neuroleptic Revenue by Type (2021-2026) & (US$ Million) Table 136. China Neuroleptic Revenue by Type (2027-2032) & (US$ Million) Table 137. China Neuroleptic Sales by Type (2021-2026) & (K Units) Table 138. China Neuroleptic Sales by Type (2027-2032) & (K Units) Table 139. China Neuroleptic Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Neuroleptic Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Neuroleptic Revenue by Application (2021-2026) & (US$ Million) Table 142. China Neuroleptic Revenue by Application (2027-2032) & (US$ Million) Table 143. China Neuroleptic Sales by Application (2021-2026) & (K Units) Table 144. China Neuroleptic Sales by Application (2027-2032) & (K Units) Table 145. China Neuroleptic Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Neuroleptic Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Neuroleptic Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Neuroleptic Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Neuroleptic Sales by Type (2021-2026) & (K Units) Table 150. Asia Neuroleptic Sales by Type (2027-2032) & (K Units) Table 151. Asia Neuroleptic Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Neuroleptic Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Neuroleptic Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Neuroleptic Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Neuroleptic Sales by Application (2021-2026) & (K Units) Table 156. Asia Neuroleptic Sales by Application (2027-2032) & (K Units) Table 157. Asia Neuroleptic Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Neuroleptic Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Neuroleptic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Neuroleptic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Neuroleptic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia Neuroleptic Sales by Country (2021-2026) & (K Units) Table 164. Asia Neuroleptic Sales by Country (2027-2032) & (K Units) Table 165. Asia Neuroleptic Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Neuroleptic Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Neuroleptic Revenue (2021-2032) & (US$ Million) Table 168. South Korea Neuroleptic Revenue (2021-2032) & (US$ Million) Table 169. India Neuroleptic Revenue (2021-2032) & (US$ Million) Table 170. Australia Neuroleptic Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Neuroleptic Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Neuroleptic Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Neuroleptic Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Neuroleptic Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Neuroleptic Sales by Type (2021-2026) & (K Units) Table 176. SAMEA Neuroleptic Sales by Type (2027-2032) & (K Units) Table 177. SAMEA Neuroleptic Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Neuroleptic Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Neuroleptic Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Neuroleptic Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Neuroleptic Sales by Application (2021-2026) & (K Units) Table 182. SAMEA Neuroleptic Sales by Application (2027-2032) & (K Units) Table 183. SAMEA Neuroleptic Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Neuroleptic Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Neuroleptic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Neuroleptic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Neuroleptic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA Neuroleptic Sales by Country (2021-2026) & (K Units) Table 190. SAMEA Neuroleptic Sales by Country (2027-2032) & (K Units) Table 191. SAMEA Neuroleptic Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Neuroleptic Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Neuroleptic Revenue (2021-2032) & (US$ Million) Table 194. Argentina Neuroleptic Revenue (2021-2032) & (US$ Million) Table 195. Chile Neuroleptic Revenue (2021-2032) & (US$ Million) Table 196. Colombia Neuroleptic Revenue (2021-2032) & (US$ Million) Table 197. Peru Neuroleptic Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Neuroleptic Revenue (2021-2032) & (US$ Million) Table 199. Israel Neuroleptic Revenue (2021-2032) & (US$ Million) Table 200. UAE Neuroleptic Revenue (2021-2032) & (US$ Million) Table 201. Turkey Neuroleptic Revenue (2021-2032) & (US$ Million) Table 202. Iran Neuroleptic Revenue (2021-2032) & (US$ Million) Table 203. Egypt Neuroleptic Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Neuroleptic Distributors List Table 207. Neuroleptic Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Neuroleptic Image Figure 2. Global Neuroleptic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroleptic Market Size Share 2021 VS 2025 VS 2032 Figure 4. Droperidol Image Figure 5. Midazolam Image Figure 6. Global Neuroleptic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Neuroleptic Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Care Image Figure 9. Scientific Research Image Figure 10. Others Image Figure 11. Global Neuroleptic Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Neuroleptic Revenue (2021-2032) & (US$ Million) Figure 13. Global Neuroleptic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Neuroleptic Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Neuroleptic Revenue Market Share by Region (2021-2032) Figure 16. Global Neuroleptic Sales (2021-2032) & (K Units) Figure 17. Global Neuroleptic Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Neuroleptic Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Neuroleptic Sales YoY (2021-2032) & (K Units) Figure 20. Europe Neuroleptic Sales YoY (2021-2032) & (K Units) Figure 21. China Neuroleptic Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Neuroleptic Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Neuroleptic Sales YoY (2021-2032) & (K Units) Figure 24. Global Neuroleptic Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Neuroleptic Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Neuroleptic Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Neuroleptic Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Neuroleptic Revenue Market Share by Type (2021-2032) Figure 30. Global Neuroleptic Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Neuroleptic Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Neuroleptic Sales Market Share by Type (2021-2032) Figure 33. Global Neuroleptic Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Neuroleptic Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Neuroleptic Revenue Market Share by Application (2021-2032) Figure 36. Global Neuroleptic Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Neuroleptic Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Neuroleptic Sales Market Share by Application (2021-2032) Figure 39. North America Neuroleptic Revenue Share by Type (2021-2032) Figure 40. North America Neuroleptic Sales Share by Type (2021-2032) Figure 41. North America Neuroleptic Revenue Share by Application (2021-2032) Figure 42. North America Neuroleptic Sales Share by Application (2021-2032) Figure 43. North America Neuroleptic Revenue Share by Country (2021-2032) Figure 44. North America Neuroleptic Sales Share by Country (2021-2032) Figure 45. Europe Neuroleptic Revenue Share by Type (2021-2032) Figure 46. Europe Neuroleptic Sales Share by Type (2021-2032) Figure 47. Europe Neuroleptic Revenue Share by Application (2021-2032) Figure 48. Europe Neuroleptic Sales Share by Application (2021-2032) Figure 49. Europe Neuroleptic Revenue Share by Country (2021-2032) Figure 50. Europe Neuroleptic Sales Share by Country (2021-2032) Figure 51. China Neuroleptic Revenue Share by Type (2021-2032) Figure 52. China Neuroleptic Sales Share by Type (2021-2032) Figure 53. China Neuroleptic Revenue Share by Application (2021-2032) Figure 54. China Neuroleptic Sales Share by Application (2021-2032) Figure 55. Asia Neuroleptic Revenue Share by Type (2021-2032) Figure 56. Asia Neuroleptic Sales Share by Type (2021-2032) Figure 57. Asia Neuroleptic Revenue Share by Application (2021-2032) Figure 58. Asia Neuroleptic Sales Share by Application (2021-2032) Figure 59. Asia Neuroleptic Revenue Share by Country (2021-2032) Figure 60. Asia Neuroleptic Sales Share by Country (2021-2032) Figure 61. SAMEA Neuroleptic Revenue Share by Type (2021-2032) Figure 62. SAMEA Neuroleptic Sales Share by Type (2021-2032) Figure 63. SAMEA Neuroleptic Revenue Share by Application (2021-2032) Figure 64. SAMEA Neuroleptic Sales Share by Application (2021-2032) Figure 65. SAMEA Neuroleptic Revenue Share by Country (2021-2032) Figure 66. SAMEA Neuroleptic Sales Share by Country (2021-2032) Figure 67. Neuroleptic Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Neuroleptic Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Droperidol
  • Midazolam
Applications
  • Medical Care
  • Scientific Research
  • Others
Companies covered
  • Johnson & Johnso
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neuroleptic Market by Type
  3. 1.2.1 Global Neuroleptic Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Droperidol
  5. 1.2.3 Midazolam
  6. 1.3 Neuroleptic Market by Application
  7. 1.3.1 Global Neuroleptic Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Care
  9. 1.3.3 Scientific Research
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Neuroleptic Market Dynamics
  1. 2.1 Neuroleptic Industry Trends
  2. 2.2 Neuroleptic Industry Drivers
  3. 2.3 Neuroleptic Industry Opportunities and Challenges
  4. 2.4 Neuroleptic Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neuroleptic Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neuroleptic Revenue by Region
  3. 3.2.1 Global Neuroleptic Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neuroleptic Revenue by Region (2021-2026)
  5. 3.2.3 Global Neuroleptic Revenue by Region (2027-2032)
  6. 3.2.4 Global Neuroleptic Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neuroleptic Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neuroleptic Sales by Region
  9. 3.4.1 Global Neuroleptic Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neuroleptic Sales by Region (2021-2026)
  11. 3.4.3 Global Neuroleptic Sales by Region (2027-2032)
  12. 3.4.4 Global Neuroleptic Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neuroleptic Revenue by Manufacturers
  2. 4.1.1 Global Neuroleptic Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neuroleptic Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neuroleptic Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neuroleptic Sales by Manufacturers
  6. 4.2.1 Global Neuroleptic Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neuroleptic Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neuroleptic Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neuroleptic Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neuroleptic Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neuroleptic Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neuroleptic Manufacturers, Product Type & Application
  13. 4.7 Global Neuroleptic Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neuroleptic Market CR5 and HHI
  16. 4.8.2 2025 Neuroleptic Tier 1, Tier 2, and Tier 3
5 Neuroleptic Market by Type
  1. 5.1 Global Neuroleptic Revenue by Type
  2. 5.1.1 Global Neuroleptic Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neuroleptic Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neuroleptic Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neuroleptic Sales by Type
  6. 5.2.1 Global Neuroleptic Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neuroleptic Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Neuroleptic Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neuroleptic Price by Type
6 Neuroleptic Market by Application
  1. 6.1 Global Neuroleptic Revenue by Application
  2. 6.1.1 Global Neuroleptic Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neuroleptic Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neuroleptic Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neuroleptic Sales by Application
  6. 6.2.1 Global Neuroleptic Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neuroleptic Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Neuroleptic Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neuroleptic Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnso
  2. 7.1.1 Johnson & Johnso Company Information
  3. 7.1.2 Johnson & Johnso Business Overview
  4. 7.1.3 Johnson & Johnso Neuroleptic Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnso Neuroleptic Product Portfolio
  6. 7.1.5 Johnson & Johnso Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Neuroleptic Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Neuroleptic Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Neuroleptic Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Neuroleptic Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Neuroleptic Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Neuroleptic Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Bristol-Myers Squibb
  26. 7.5.1 Bristol-Myers Squibb Company Information
  27. 7.5.2 Bristol-Myers Squibb Business Overview
  28. 7.5.3 Bristol-Myers Squibb Neuroleptic Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bristol-Myers Squibb Neuroleptic Product Portfolio
  30. 7.5.5 Bristol-Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Neuroleptic Market Size by Type
  2. 8.1.1 North America Neuroleptic Revenue by Type (2021-2032)
  3. 8.1.2 North America Neuroleptic Sales by Type (2021-2032)
  4. 8.1.3 North America Neuroleptic Price by Type (2021-2032)
  5. 8.2 North America Neuroleptic Market Size by Application
  6. 8.2.1 North America Neuroleptic Revenue by Application (2021-2032)
  7. 8.2.2 North America Neuroleptic Sales by Application (2021-2032)
  8. 8.2.3 North America Neuroleptic Price by Application (2021-2032)
  9. 8.3 North America Neuroleptic Market Size by Country
  10. 8.3.1 North America Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neuroleptic Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neuroleptic Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neuroleptic Market Size by Type
  2. 9.1.1 Europe Neuroleptic Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neuroleptic Sales by Type (2021-2032)
  4. 9.1.3 Europe Neuroleptic Price by Type (2021-2032)
  5. 9.2 Europe Neuroleptic Market Size by Application
  6. 9.2.1 Europe Neuroleptic Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neuroleptic Sales by Application (2021-2032)
  8. 9.2.3 Europe Neuroleptic Price by Application (2021-2032)
  9. 9.3 Europe Neuroleptic Market Size by Country
  10. 9.3.1 Europe Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neuroleptic Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neuroleptic Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neuroleptic Market Size by Type
  2. 10.1.1 China Neuroleptic Revenue by Type (2021-2032)
  3. 10.1.2 China Neuroleptic Sales by Type (2021-2032)
  4. 10.1.3 China Neuroleptic Price by Type (2021-2032)
  5. 10.2 China Neuroleptic Market Size by Application
  6. 10.2.1 China Neuroleptic Revenue by Application (2021-2032)
  7. 10.2.2 China Neuroleptic Sales by Application (2021-2032)
  8. 10.2.3 China Neuroleptic Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neuroleptic Market Size by Type
  2. 11.1.1 Asia Neuroleptic Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neuroleptic Sales by Type (2021-2032)
  4. 11.1.3 Asia Neuroleptic Price by Type (2021-2032)
  5. 11.2 Asia Neuroleptic Market Size by Application
  6. 11.2.1 Asia Neuroleptic Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neuroleptic Sales by Application (2021-2032)
  8. 11.2.3 Asia Neuroleptic Price by Application (2021-2032)
  9. 11.3 Asia Neuroleptic Market Size by Country
  10. 11.3.1 Asia Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neuroleptic Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neuroleptic Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neuroleptic Market Size by Type
  2. 12.1.1 SAMEA Neuroleptic Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neuroleptic Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neuroleptic Price by Type (2021-2032)
  5. 12.2 SAMEA Neuroleptic Market Size by Application
  6. 12.2.1 SAMEA Neuroleptic Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neuroleptic Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neuroleptic Price by Application (2021-2032)
  9. 12.3 SAMEA Neuroleptic Market Size by Country
  10. 12.3.1 SAMEA Neuroleptic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neuroleptic Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neuroleptic Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neuroleptic Value Chain Analysis
  2. 13.1.1 Neuroleptic Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neuroleptic Production Mode & Process
  6. 13.2 Neuroleptic Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neuroleptic Distributors
  9. 13.2.3 Neuroleptic Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst